Literature DB >> 18345994

Coronary heart disease risk and bone mineral density among U.S. women and men.

Danielle L Broussard1, Jeanette H Magnus.   

Abstract

AIMS: Low bone mineral density (BMD) has been shown to predict cardiovascular disease (CVD) and coronary heart disease (CHD) mortality in both women and men. The purpose of the current study was to determine whether a CHD risk assessment tool might be useful for identifying persons likely to have low BMD in a multiethnic population of women and men.
METHODS: Cross-sectional data for 3881 women and men aged 50-74 years without overt CHD or stroke from the Third National Health and Nutrition Examination Survey (NHANES III) were used to explore the relationship between BMD and 10-year CHD risk, as estimated using the Framingham CHD risk prediction algorithm, in gender-stratified multiple logistic regression models.
RESULTS: When compared with women who had a <10% CHD risk, women with a 10%-19% CHD risk were 45% more likely and those with a > or =20% CHD risk were 73% more likely to have low BMD. Similar increases in low BMD risk were not detected in men.
CONCLUSIONS: In the United States, 10-year Framingham CHD risk assessment may be useful for identifying older women who should be evaluated for osteoporosis and referred for BMD measurement. The impact of such a screening strategy on fracture prevention needs further elucidation.

Entities:  

Mesh:

Year:  2008        PMID: 18345994     DOI: 10.1089/jwh.2007.0593

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  9 in total

Review 1.  Osteoporosis in chronic inflammatory disease: the role of malnutrition.

Authors:  Tiziana Montalcini; Stefano Romeo; Yvelise Ferro; Valeria Migliaccio; Carmine Gazzaruso; Arturo Pujia
Journal:  Endocrine       Date:  2012-10-09       Impact factor: 3.633

2.  Bone mineral density and cardiovascular risk factors in postmenopausal women with coronary artery disease.

Authors:  Eman M Alissa; Wafa A Alnahdi; Nabil Alama; Gordon A Ferns
Journal:  Bonekey Rep       Date:  2015-11-11

3.  Osteoporosis, osteopenia, and atherosclerotic vascular disease.

Authors:  Wilbert S Aronow
Journal:  Arch Med Sci       Date:  2011-03-08       Impact factor: 3.318

Review 4.  (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis.

Authors:  Debby den Uyl; Mike T Nurmohamed; Lilian Hd van Tuyl; Hennie G Raterman; Willem F Lems
Journal:  Arthritis Res Ther       Date:  2011-01-17       Impact factor: 5.156

Review 5.  What is the role of lifestyle behaviour change associated with non-communicable disease risk in managing musculoskeletal health conditions with special reference to chronic pain?

Authors:  Elizabeth Dean; Anne Söderlund
Journal:  BMC Musculoskelet Disord       Date:  2015-04-13       Impact factor: 2.362

6.  Peptic ulcer disease and heart disease are associated with periprosthetic fractures after total hip replacement.

Authors:  Jasvinder A Singh; David G Lewallen
Journal:  Acta Orthop       Date:  2012-08-20       Impact factor: 3.717

7.  Depressive symptoms and bone mineral density among police officers in a northeastern US City.

Authors:  Luenda E Charles; Desta Fekedulegn; Diane B Miller; Jean Wactawski-Wende; John M Violanti; Michael E Andrew; Cecil M Burchfiel
Journal:  Glob J Health Sci       Date:  2012-04-28

8.  Bone mineral density and risk of type 2 diabetes and coronary heart disease: A Mendelian randomization study.

Authors:  Wei Gan; Robert J Clarke; Anubha Mahajan; Benard Kulohoma; Hidetoshi Kitajima; Neil R Robertson; N William Rayner; Robin G Walters; Michael V Holmes; Zhengming Chen; Mark I McCarthy
Journal:  Wellcome Open Res       Date:  2017-08-22

9.  Acidic-Treated Acorn Pollen as Health Functional Food Materials for Improvement of Post-Menopausal Glucose Metabolism.

Authors:  Su Jin Nam; Soo Im Chung; Mi Young Kang
Journal:  Prev Nutr Food Sci       Date:  2020-03-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.